Cardiomyopathy is a major contributor of death amongst DMD patients (9), and, therefore, multiple approaches have been implemented to treat the cardiac phenotype, including corticosteroids, beta-blockers, angiotensin converting enzyme (ACE) inhibitors and antimineralocorticoid diuretics (10). The gene discussed is ACE; the disease is Duchenne muscular dystrophy.